The oligomeric structure of high molecular weight adiponectin

FEBS Letters

Volumn 581, Issue 5, 2007, Pages 809-814

  Suzuki, Shinji ^a   Wilson Kubalek, Elizabeth M ^b   Wert, David ^c   Tsao, Tsu Shuen ^c   Lee, David H ^a  

^a TUFTS UNIVERSITY   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF ARIZONA   (United States)

Author keywords

Adiponectin; C1q; Collagen; Octadecamer; Oligomerization

Indexed keywords

ADIPONECTIN; COMPLEMENT COMPONENT C1Q; OLIGOMER;

ADIPOCYTE; ANIMAL CELL; ARTICLE; CENTRIFUGATION; COW; ELECTRON MICROSCOPY; GEL ELECTROPHORESIS; LIGHT SCATTERING; MOLECULAR WEIGHT; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN STRUCTURE; SEDIMENTATION; TRANSMISSION ELECTRON MICROSCOPY; WESTERN BLOTTING;

3T3-L1 CELLS; ADIPOCYTES; ADIPONECTIN; ANIMALS; CATTLE; COMPLEMENT C1Q; DIABETES MELLITUS, TYPE 2; HUMANS; MICE; MICROSCOPY, ELECTRON; MOLECULAR WEIGHT; PROTEIN STRUCTURE, QUATERNARY;

BOVINAE;

EID: 33847109769     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2007.01.046     Document Type: Article

References (32)

1. Nawrocki A.R., et al. Mice lacking adiponectin show decreased hepatic insulin sensitivity and reduced responsiveness to peroxisome proliferator-activated receptor gamma agonists. J. Biol. Chem. 281 (2006) 2654-2660
2. Fruebis J., et al. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc. Natl. Acad. Sci. USA 98 (2001) 2005-2010
3. Yamauchi T., et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat. Med. 8 (2002) 1288-1295
4. Tomas E., et al. Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation. Proc. Natl. Acad. Sci. USA 99 (2002) 16309-16313
5. Tsao T.-S., Murrey H.E., Hug C., Lee D.H., and Lodish H.F. Oligomerization state-dependent activation of NF-κB signaling pathway by adipocyte complement-related protein of 30 kDa (Acrp30). J. Biol. Chem. 277 (2002) 29359-29362
6. Pajvani U.B., et al. Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin. Implications for metabolic regulation and bioactivity. J. Biol. Chem. 278 (2003) 9073-9085
7. Scherer P.E., Williams S., Fogliano M., Baldini G., and Lodish H.F. A novel serum protein similar to C1q, produced exclusively in adipocytes. J. Biol. Chem. 270 (1995) 26746-26749
8. Hug C., et al. T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/adiponectin. Proc. Natl. Acad. Sci. USA 101 (2004) 10308-10313
9. Tsao T.S., et al. Role of disulfide bonds in Acrp30/adiponectin structure and signaling specificity. Different oligomers activate different signal transduction pathways. J. Biol. Chem. 278 (2003) 50810-50817
10. Neumeier M., et al. Different effects of adiponectin isoforms in human monocytic cells. J. Leukoc. Biol. 79 (2006) 803-808
11. Kobayashi H., et al. Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin. Circ. Res. 94 (2004) e27-e31
12. Wang Y., et al. Adiponectin inhibits cell proliferation by interacting with several growth factors in an oligomerization-dependent manner. J. Biol. Chem. 280 (2005) 18341-18347
13. Xu A., et al. Testosterone selectively reduces the high molecular weight form of adiponectin by inhibiting its secretion from adipocytes. J. Biol. Chem. 280 (2005) 18073-18080
14. Gui Y., Silha J.V., and Murphy L.J. Sexual dimorphism and regulation of resistin, adiponectin, and leptin expression in the mouse. Obes. Res. 12 (2004) 1481-1491
15. Waki H., et al. Impaired multimerization of human adiponectin mutants associated with diabetes. Molecular structure and multimer formation of adiponectin. J. Biol. Chem. 278 (2003) 40352-40363
16. Hotta K., et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler. Thromb. Vasc. Biol. 20 (2000) 1595-1599
17. Peake P.W., Kriketos A.D., Campbell L.V., Shen Y., and Charlesworth J.A. The metabolism of isoforms of human adiponectin: studies in human subjects and in experimental animals. Eur. J. Endocrinol. 153 (2005) 409-417
18. Pajvani U.B., et al. Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity. J. Biol. Chem. 279 (2004) 12152-12162
19. Fisher F.F., et al. Serum high molecular weight complex of adiponectin correlates better with glucose tolerance than total serum adiponectin in Indo-Asian males. Diabetologia 48 (2005) 1084-1087
20. Lara-Castro C., Luo N., Wallace P., Klein R.L., and Garvey W.T. Adiponectin multimeric complexes and the metabolic syndrome trait cluster. Diabetes 55 (2006) 249-259
21. Aso Y., et al. Comparison of serum high-molecular weight (HMW) adiponectin with total adiponectin concentrations in type 2 diabetic patients with coronary artery disease using a novel enzyme-linked immunosorbent assay to detect HMW adiponectin. Diabetes 55 (2006) 1954-1960
22. Kadowaki T., et al. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J. Clin. Invest. 116 (2006) 1784-1792
23. Sato C., Yasukawa Z., Honda N., Matsuda T., and Kitajima K. Identification and adipocyte differentiation-dependent expression of the unique disialic acid residue in an adipose tissue-specific glycoprotein, adipo Q. J. Biol. Chem. 276 (2001) 28849-28856
24. Wang Y., et al. Proteomic and functional characterization of endogenous adiponectin purified from fetal bovine serum. Proteomics 4 (2004) 3933-3942
25. Johnson M.L., Correia J.J., Yphantis D.A., and Halvorson H.R. Analysis of data from the analytical ultracentrifuge by nonlinear least-squares techniques. Biophys. J. 36 (1981) 575-588
26. Frisken B.J. Revisiting the method of cumulants for the analysis of dynamic light-scattering data. Appl. Optics 40 (2001) 4087-4091
27. Teller D.C. Accessible area, packing volumes and interaction surfaces of globular proteins. Nature 260 (1976) 729-731
28. Laue T.M., Shah B.D., Ridgeway T.M., and Pelletier S.L. In: Harding S., and Rowe A. (Eds). Analytical Ultracentrifugation in Biochemistry and Polymer Science (1992), Redwood Press Ltd, Melksham, UK 90-125
29. Liberti P.A., and Paul S.M. Gross conformation of C1q: a subcomponent of the first component of complement. Biochemistry 17 (1978) 1952-1958
30. Shelton E., Yonemasu K., and Stroud R.M. Ultrastructure of the human complement component, Clq (negative staining-glutamine synthetase-biologically active Clq). Proc. Natl. Acad. Sci. USA 69 (1972) 65-68
31. Slayter H.S., Alexander R.J., and Steiner L.A. Electron microscopy of the complement protein C1q from the bullfrog, Rana catesbeiana. Eur. J. Immunol. 13 (1983) 102-106
32. Brodsky-Doyle B., Leonard K.R., and Reid K.B. Circular-dichroism and electron-microscopy studies of human subcomponent C1q before and after limited proteolysis by pepsin. Biochem J. 159 (1976) 279-286